ALANA WILLIS: Open Payments
NPI 1447838503 · PLANTATION, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,701 in 112 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,961 · 2025 $2,701
Food & beverage: $2,595Education: $106
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $408 |
| ABBVIE INC. | 18 | $343 |
| Organogenesis Inc. | 11 | $306 |
| Regeneron Healthcare Solutions, Inc. | 9 | $267 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $205 |
| UCB, Inc. | 7 | $185 |
| Janssen Biotech, Inc. | 7 | $177 |
| Galderma Laboratories, L.P. | 10 | $141 |
| PFIZER INC. | 5 | $116 |
| Lilly USA, LLC | 5 | $112 |
Products named: DUPIXENT, VIA MATRIX, Bimzelx, TREMFYA, SKYRIZI, RINVOQ, CIBINQO, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
